Original Research

Published on 27 Jun 2024

Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance

in Gynecological Oncology

Yani Berckmans
Hila M. Ene
Kerem Ben-Meir
Antonia Martinez-Conde
Roxanne Wouters
Bieke Van den Ende
Sara Van Mechelen
Roni Monin
Roni Frechtel-Gerzi
Hila Gabay

Frontiers in Oncology

doi 10.3389/fonc.2024.1402851

1,864 views

Original Research

Published on 26 Jun 2024

Elucidating prognosis in cervical squamous cell carcinoma and endocervical adenocarcinoma: a novel anoikis-related gene signature model

in Gynecological Oncology

Mingwei- Wang
Qiaohui- Ying
Ru Ding
Yuncan- Xing
Jue Wang
Yiming- Pan
Bo Pan
Guifen- Xiang
Zhong Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1352638

1,022 views

Case Report

Published on 26 Jun 2024

Primary cervical malignant melanoma that was successfully treated with pembrolizumab: a case report and literature review

in Gynecological Oncology

Mengpei Zhang
Rutie Yin
Liang Song
Lan Zhong
Ruiyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1400257

787 views

Original Research

Published on 25 Jun 2024

Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches

in Gynecological Oncology

Konrad Stawiski
Renée T. Fortner
Luca Pestarino
Sinan U. Umu
Rudolf Kaaks
Trine B. Rounge
Kevin M. Elias
Wojciech Fendler
Hilde Langseth

Frontiers in Oncology

doi 10.3389/fonc.2024.1389066

1,107 views

Review

Published on 24 Jun 2024

Comparative effectiveness of neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stages IB2 to IIB of cervical cancer: a meta-analysis

in Gynecological Oncology

Yue Gao
Huali Wang
Meng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1426002

883 views

Original Research

Published on 20 Jun 2024

Ultrasonographic and clinicopathological features of pelvic yolk sac tumors in women: a single-center retrospective analysis

in Gynecological Oncology

Mei Chen
Shengmin Zhang
Xiupeng Jia
Youfeng Xu
Yaping Wei
Shusheng Liao

Frontiers in Oncology

doi 10.3389/fonc.2024.1417761

810 views

Review

Published on 19 Jun 2024

Mexican consensus about surgical treatment in early-stage cervicouterine cancer

in Gynecological Oncology

Cindy A. Nájera-Muñoz
Raúl Hernández-Romero
David Isla-Ortiz
Rosa A. Salcedo-Hernández

Frontiers in Oncology

doi 10.3389/fonc.2024.1385887

1,058 views

Original Research

Published on 17 Jun 2024

Real-world TRAE association between niraparib and platinum-based chemotherapy

in Gynecological Oncology

Linli Wang
Jieli Zhou
Haibin Wang
Wenling Han
Chunyun Fang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390820

942 views

Original Research

Published on 10 Jun 2024

The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy

in Gynecological Oncology

Yiqing Xu
Yi-Ju Amy Chen
Yunhong Wu
Angela Saverimuthu
Archana Jadhav
Rehana Bhuiyan
Jason Sandler
Jiang Yio
Vivek Kumar

Frontiers in Oncology

doi 10.3389/fonc.2024.1372482

1,080 views

Case Report

Published on 06 Jun 2024

Recurrent mucinous carcinoma with sarcomatoid and sarcomatous mural nodules: a case report and literature review

in Gynecological Oncology

Simin Li
Jingyu Zhu
Na Jiang
Yanping Guo
Meng Hou
Xi Liu
Jin Yang
Xiaofeng Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1387700

896 views

Review

Published on 06 Jun 2024

Progress in the study of antibody-drug conjugates for the treatment of cervical cancer

in Gynecological Oncology

Congcong Zhai
Yan Cui
Ling Guo
Cixiang Chen
Yanfang Song
Jinghua Zhong
Yili Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1395784

1,346 views

Review

Published on 04 Jun 2024

Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group

in Gynecological Oncology

Nadja Stiegeler
Dale W. Garsed
George Au-Yeung
David D. L. Bowtell
Viola Heinzelmann-Schwarz
Tibor A. Zwimpfer

Frontiers in Oncology

doi 10.3389/fonc.2024.1387281

2,821 views

Review

Published on 30 May 2024

Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics

in Gynecological Oncology

Dharvind Balan
Nirmala Chandralega Kampan
Magdalena Plebanski
Nor Haslinda Abd Aziz

Frontiers in Oncology

doi 10.3389/fonc.2024.1388663

2,212 views

Original Research

Published on 28 May 2024

Performance of P16INK4a immunocytochemical stain in facilitating cytology interpretation of HSIL for HPV-positive women aged 50 and above

in Gynecological Oncology

Jun Hou
Hui Du
Chun Wang
Fangbin Song
Xinfeng Qu
Ruifang Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1332172

1,357 views

Original Research

Published on 28 May 2024

Effect of different treatment modalities on the prognosis of patients with stage IIIC cervical cancer

in Gynecological Oncology

Xiaoman Su
Jiazhen Huang
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1405778

836 views

Original Research

Published on 28 May 2024

Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study

in Gynecological Oncology

Jing Huang
Danyi Du
Hailong Chen
Deping Luo
Qi Wang
Chan Li
Yuanxiang Li
Ying Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399502

767 views
1 citation

Navigation group

Articles

Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance

Elucidating prognosis in cervical squamous cell carcinoma and endocervical adenocarcinoma: a novel anoikis-related gene signature model

Primary cervical malignant melanoma that was successfully treated with pembrolizumab: a case report and literature review

Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches

Comparative effectiveness of neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stages IB2 to IIB of cervical cancer: a meta-analysis

Ultrasonographic and clinicopathological features of pelvic yolk sac tumors in women: a single-center retrospective analysis

Mexican consensus about surgical treatment in early-stage cervicouterine cancer

Real-world TRAE association between niraparib and platinum-based chemotherapy

The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy

Recurrent mucinous carcinoma with sarcomatoid and sarcomatous mural nodules: a case report and literature review

Progress in the study of antibody-drug conjugates for the treatment of cervical cancer

Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group

Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics

Performance of P16INK4a immunocytochemical stain in facilitating cytology interpretation of HSIL for HPV-positive women aged 50 and above

Effect of different treatment modalities on the prognosis of patients with stage IIIC cervical cancer

Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study